| UNC-1215 |
UNC1215 |
1415800-43-9 |
| NVP-BHG712 |
4-甲基-3-[[1-甲基-6-(3-吡啶基)-1H-吡唑并[3,4-D]嘧啶-4-基]氨基]-N-[3-(三氟甲基)苯基]苯甲酰胺 |
940310-85-0 |
| PF 573228 |
6-[(4-((3-(甲磺酰基)苄基)氨基)-5-三氟甲基嘧啶-2-基)氨基]-3,4-二氢-1H-喹啉-2-酮 |
869288-64-2 |
| 4-[3-(Trifluoromethyl)-2-pyridinyl]-N-[5-(trifluoromethyl)-2-pyridinyl]-1-piperazinecarboxamide |
4-(3-(三氟甲基)吡啶-2-基)-N-(5-三氟甲基)吡啶-2-基)哌嗪-1-甲酰胺 |
821768-06-3 |
| ALK inhibitor 2 |
2-[[5-氯-2-[[2-甲氧基-4-(4-甲基-1-哌嗪基)苯基]氨基]-4-嘧啶基]氨基]-N-甲基苯磺酰胺 |
761438-38-4 |
| ZM 306416 |
ZM 306416 |
690206-97-4 |
| (E)-N-[4-(1-BENZOYL-PIPERIDIN-4-YL)-BUTYL]-3-PYRIDIN-3-YL-ACRYLAMIDE |
(2E)-N-[4-(1-苯甲酰基-4-哌啶基)丁基]-3-(3-吡啶基)-2-丙烯酰胺 |
658084-64-1 |
| 7-(Diethylamino)coumarin-3-carboxylic acid |
7-(二乙胺基）-2-氧代-2-苯并吡喃-3-羧酸 |
50995-74-9 |
| JNJ7777120 |
JNJ7777120 |
459168-41-3 |
| ZLN005 |
ZLN-005 |
49671-76-3 |
| 4-Methoxy-N-(2,4,6-triMethylphenyl)benzenesulfonaMide, 97% |
4-甲氧基-N-(2,4,6-三甲基苯)苯磺酰胺 |
349085-82-1 |
| 4-AMINO-1-TERT-BUTYL-3-(1'-NAPHTHYL)PYRAZOLO[3,4-D]PYRIMIDINE |
4 -氨基- 1 -叔丁基- 3 -(1' -萘基)吡唑并[3,4 - D]嘧啶 |
221243-82-9 |
| UNC 1999 |
UNC1999 |
1431612-23-5 |
| EI1 |
6-氰基-N-[(1,2-二氢-4,6-二甲基-2-氧代-3-吡啶基)甲基]-1-(1-乙基丙基)-1H-吲哚-4-甲酰胺 |
1418308-27-6 |
| AZ191 |
DYRK1B抑制剂(AZ191) |
1594092-37-1 |
| 4-[6-[4-(1-Methylethoxy)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]-quinoline |
DMH1 |
1206711-16-1 |
| 5-[6-(4-Methoxyphenyl)pyrazolo[1,5-a] |
(ML347) |
1062368-49-3 |
| GNF 5837 |
GNF 5837 |
1033769-28-6 |
| PP1 |
蛋白磷酸酯酶-1(抗原) |
172889-26-8 |
| PP2 |
PP2 |
172889-27-9 |
